Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne
- The Company is developing an enhanced immunosuppressive regimen in consultation with…
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
June 13, 2025 16:22 ET Â | Source: 23andMe, Inc. TTAM Commits to…
Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million
VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) -- Â Rakovina Therapeutics Inc.…
Consumer Choice Center Advocates for Significant Revisions to WHO Governance and Operations Amidst Approval of Increased Mandatory Membership
NEW DELHI, June 6, 2025 /PRNewswire/ -- The World Health Organization (WHO)…
